Current Liabilities
Operating Lease Liabilities (Current)
Bristol-Myers Squibb Operating Lease Liabilities (Current) decreased by 1.5% to $199M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.7%, from $172M to $199M. Over 5 years (FY 2020 to FY 2025), Operating Lease Liabilities (Current) shows an upward trend with a 4.3% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalLower is better
VolatilityStable
First reportedQ4 2018
Last reportedQ1 2026Apr 30, 2026
How to read this metric
An increase reflects higher near-term fixed cash obligations, which can impact short-term liquidity.
Detailed definition
This figure represents the portion of total operating lease obligations that are due to be paid within the next twelve m...
Peer comparison
Standardized under IFRS 16 and ASC 842, making it highly comparable across the pharmaceutical sector.
Metric ID:
operating_lease_liabilities_currentHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $173M | $173M | $169M | $171M | $167M | $167M | $136M | $171M | $168M | $150M | $162M | $169M | $177M | $165M | $181M | $172M | $194M | $214M | $202M | $199M |
| QoQ Change | — | +0.0% | -2.3% | +1.2% | -2.3% | +0.0% | -18.6% | +25.7% | -1.8% | -10.7% | +8.0% | +4.3% | +4.7% | -6.8% | +9.7% | -5.0% | +12.8% | +10.3% | -5.6% | -1.5% |
| YoY Change | — | — | — | — | -3.5% | -3.5% | -19.5% | +0.0% | +0.6% | -10.2% | +19.1% | -1.2% | +5.4% | +10.0% | +11.7% | +1.8% | +9.6% | +29.7% | +11.6% | +15.7% |
Range$136M – $214M
CAGR+3.0%
Avg YoY Growth+4.8%
Median YoY Growth+3.6%
Current Streak2 quarters decline
Operating Lease Liabilities (Current) at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's operating lease liabilities (current)?
- Bristol-Myers Squibb (BMY) reported operating lease liabilities (current) of $199M in Q1 2026.
- How has Bristol-Myers Squibb's operating lease liabilities (current) changed year-over-year?
- Bristol-Myers Squibb's operating lease liabilities (current) increased by 15.7% year-over-year, from $172M to $199M.
- What is the long-term trend for Bristol-Myers Squibb's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's operating lease liabilities (current) has grown at a 4.3% compound annual growth rate (CAGR), from $164M to $202M.
- What does operating lease liabilities (current) mean?
- The amount of lease payments due within the next year.